On ECHEMI
Home > Drugs > Levofloxacin Hydrochloride Eye Drops

Levofloxacin Hydrochloride Eye Drops

Function and Efficacy

This product is the L-isomer of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity, thereby inhibiting the replication of cell DNA. This product has the characteristics of a broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, and some Escherichia coli. It also has good antibacterial effects on some Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.

Ingredients

Levofloxacin hydrochloride.

Name Description Content CAS NO. Manufacturer
Levofloxacin hydrochlorideIngredients

This product is the L-isomer of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity, thereby inhibiting the replication of cell DNA. This product has the characteristics of a broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, and some Escherichia coli. It also has good antibacterial effects on some Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.

More
177325-13-2 18

Appearance

This product is a light yellow-green clear liquid.

Indication

This product is suitable for the treatment of bacterial conjunctivitis and bacterial keratitis caused by sensitive bacteria.

Usage and Dosage

Drop the product into the conjunctival sac of the affected eye. 3-5 times a day, 1-2 drops each time. Recommended course of treatment: 7 days for bacterial conjunctivitis, 10-14 days for bacterial keratitis. Or follow the doctor's advice.

Adverse Reactions

The most commonly reported adverse reactions are temporary decreased vision, fever, transient eye burning, eye pain or discomfort, pharyngitis and photophobia, with an incidence of about 1% to 3%. Adverse reactions with an incidence of less than 1% include: allergies, eyelid edema, dry eyes and itching.

Precautions

Patients who are allergic to levofloxacin hydrochloride or other quinolones or any components of this product are contraindicated.

Special Population Medication

Precautions for children: The efficacy and safety of this product for infants under 1 year old have not been established. Oral administration of quinolones to immature animals can cause arthritis. This product can only be used when it is judged that the potential benefits of the drug outweigh the potential risks to children. Or follow the doctor's advice. Precautions for pregnancy and lactation: Since there are no adequate controlled studies on pregnant women, this product can only be used for pregnant women when it is judged that the potential benefits of the drug outweigh the potential risks to the fetus. Based on the data of ofloxacin, it is speculated that levofloxacin can be excreted through human milk, so it should be used with caution in lactating women. Precautions for the elderly: The efficacy and safety of this product for the elderly are not significantly different from those for other adult patients.

Drug Interactions

The study of drug interactions of this product has not been conducted yet. However, it has been shown that levofloxacin can increase the blood concentration of theophylline when taken simultaneously with theophylline. If it is necessary to use it simultaneously, the blood concentration of theophylline should be monitored and the dosage should be adjusted accordingly. When used simultaneously with warfarin or its derivatives, the prothrombin time or other coagulation tests should be monitored. When used simultaneously with non-steroidal anti-inflammatory drugs, there is a possibility of convulsion. When used simultaneously with oral hypoglycemic drugs, it may cause blood sugar disorders, including hyperglycemia and hypoglycemia. Therefore, attention should be paid to monitoring blood sugar concentration during medication. Once hypoglycemia occurs, this product should be discontinued immediately and appropriate treatment should be given.

Storage

Keep away from light, tightly closed, in a cool place.

Packaging Specification

Calculated according to C18H20FN3O4 (1) 5ml: 15mg (2) 7ml: 21mg

Validity Period

24 months

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.